• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Skip to navigation
Close Ad

The Spoon

Daily news and analysis about the food tech revolution

  • Home
  • Podcasts
  • Events
  • Newsletter
  • Connect
    • Custom Events
    • Slack
    • RSS
    • Send us a Tip
  • Advertise
  • Consulting
  • About
The Spoon
  • Home
  • Podcasts
  • Newsletter
  • Events
  • Advertise
  • About

cultured milk

May 20, 2021

A Spanish Dairy Company Has Launched a Startup Incubator to Help Cultured Milk Companies

Pascual Innoventures, the open innovation arm of Spanish dairy company Calidad Pascual, has launched what it says is the world’s first incubator program for cellular agriculture in the dairy industry. Dubbed Mylkubator, the program will select and work with startups hoping to change the dairy industry through the development of alternative proteins. 

The program, which is supported by investment network Eatable Adventures and technology partner CNTA, will choose up to 10 startups to join the six-month hybrid program. Either in-person or virtually (or both), companies will work with mentors and get access to Pascual’s R&D facilities to develop and test their products. 

On a high level, cultured milk is created by growing mammary gland cells in an external environment (like a bioreactor) that mimics the one found inside mammals (like a cow). Micronutrients get converted into milk, which can then be harvested and purified. The process requires expertise in a number of different areas, from cell-growth media to machine learning modules that can optimize the production process. Different types of milk, including cow’s milk and human breastmilk, can be made from this process.

To that end, novel growth media, cell-growth techniques, and improvement of cell lines are among the topics the program says it is looking to find companies. And in addition to cellular ag, startups working with fermentation-based solutions or developing applied technologies like machine learning and biorecators are also welcome to apply. 

In the realm of alternative protein, the number of well-known companies currently developing milk analogues via cellular agriculture is still pretty small, particularly in comparison to the glut of cell-based meat makers. Turtle Tree Labs and Biomilq are the most well-known companies at this point.

On the other hand, companies like Perfect Day and ReMilk make milk analogues via fermentation, a process now seen as the third-pillar of alternative protein.  

Startups working with both methods are invited to apply for Mylkubator’s program. Those chosen will get a chance to prototype, test and scale their products, in addition to meeting with mentors and potential investors. The application process is open now.

December 17, 2020

TurtleTree Labs Raises $6.2M for its Cell-Cultured Milk

TurtleTree Labs, which is best known for developing cell-based human breastmilk, announced today that it has raised a $6.2 million Pre-A round of funding. Green Monday Ventures, Eat Beyond Global, KBW Ventures, and Verso Capital all participated in the round. This brings the total amount of announced funding for the company to $9.4 million.

While TurtleTree’s breastmilk endeavors may grab most of the headlines, the company is actually working on re-creating a number of different types of milk using cell cultures. As we’ve written previously:

TurtleTree Labs uses cellular agriculture to grow mammary gland cells in a nutrient rich bath that actually lactate milk. This company is initially focusing on re-creating human breast milk, and will follow that up with cow milk. Because they are creating milk in the lab, scientists can alter the milk to give it different attributes like higher or lower fat or cholesterol.

In its press announcement, TurtleTree said it will use the new funds to “accelerate research and production of functional, bioactive proteins and complex sugars found in human milk.”

Both TurtleTree and fellow cultured breastmilk company Biomilq have made headlines throughout 2020. Both companies raised funding rounds in June. And last month, we learned of Biomilq’s plan to use biopsies to create individualized cultured breastmilk.

The ability to create human breastmilk in the lab may sound kind of scary at first, but it has the potential to do a lot of good. Cultured breastmilk doesn’t rely on animal-based dairy like other infant formulas, so it could have an environmental benefit. And cultured breastmilk could also help mothers who for biological, economic or societal reasons, can’t breastfeed their babies as much as they’d like.

There are still regulatory hurdles that must be overcome before we’ll see cultured breastmilk hit the market. But given the investor interest we’ve seen in the space this year, expect to see more technological breakthroughs in 2021.

June 25, 2020

TurtleTree Labs Raises $3.2M Seed Round for its Cultured Human Breast Milk

Turtle Tree Labs, a Singapore-based startup that creates milk from mammalian cells, announced yesterday that it has raised a $3.2 million seed round of funding. Green Monday Ventures, KBW Ventures, CPT Capital, Artesian, and New Luna Ventures all participated in the round.

As we’ve covered previously, TurtleTree Labs uses cellular agriculture to grow mammary gland cells in a nutrient rich bath that actually lactate milk. This company is initially focusing on re-creating human breast milk, and will follow that up with cow milk. Because they are creating milk in the lab, scientists can alter the milk to give it different attributes like higher or lower fat or cholesterol.

When we spoke to TurtleTree at the end of 2019, the company had plans to debut its first glass of human breast milk in Q1 of 2021 and enter the market at the end of 2021. We don’t know if the COVID-19 pandemic has altered any of those plans, but in its funding announcement, TurtleTree said that the Singapore government has been supportive, allowing the company to continue its work apace.

Cultured breast milk seems to be a pretty hot space right now. TurtleTree’s funding comes just a week after BIOMILQ raised $3.5 million for its cultured breast milk solution.

It’s not hard to understand why cultured human breast milk is attracting funding. It has the potential to provide a healthier and more environmentally friendly option for women who are unable to produce enough breast milk on their own because of biological or environmental reasons.

That is still years away, however, as companies like TurtleTree need to continue development of its product and scale up to make its milk more affordable. This new round of funding will definitely help that.

June 16, 2020

BIOMILQ Raises $3.5M for its Cultured Human Breastmilk

BIOMILQ, which creates cultured human breastmilk in a lab, announced today that it has raised $3.5 million in funding. The round was led by Breakthrough Energy Ventures with participation from Shazi Visram, founder of Happy Family Brands and healthynest.

We’ve covered BIOMILQ before, writing about the company:

The startup was founded last year by Michelle Egger, a food scientist who previously worked in dairy R&D at General Mills, and Dr. Leila Strickland, a cell biologist who first conceptualized the technology in 2013 while breastfeeding her own daughter. The two met in the Research Triangle and created a patent-pending technology in which they trigger human mammary gland cells, kept alive by a constant stream of nutrients, to lactate. They then collect the resulting breastmilk.

According to the National Center for Biotechnology Information, “Breast milk is uniquely suited to the human infant’s nutritional needs and is a live substance with unparalleled immunological and anti-inflammatory properties that protect against a host of illnesses and diseases for both mothers and children.1”

However, breastfeeding isn’t always possible for number of reasons including low milk production, medical challenges, or the ongoing stigmas attached to breastfeeding/pumping in public or work places. BIOMILQ hopes its cultured breastmilk can serve as a healthier and more environmentally friendly option to dairy-based formulas.

BIOMILQ isn’t the only company looking to recreate breastmilk in the lab. Over in Singapore, TurtleTree Labs uses mammary gland cells in a nutrient rich bath to lactate milk. BIOMILQ told The Spoon previously that its technology does not require the nutrient bath and is a “much cleaner technology.”

The company is still very early on and a concept as new as cultured human breastmilk will undoubtedly face scrutiny from regulators, so there is a lot of work yet to be done. BIOMILQ said it will use its new funding to work on production, hire out its team and engage with key stakeholders including families, pediatricians and the breastfeeding community.

Primary Sidebar

Footer

  • About
  • Sponsor the Spoon
  • The Spoon Events
  • Spoon Plus

© 2016–2025 The Spoon. All rights reserved.

  • Facebook
  • Instagram
  • LinkedIn
  • RSS
  • Twitter
  • YouTube
 

Loading Comments...